PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Understanding how abnormal embryos self-correct may provide women with a better chance of IVF pregnancy

2024-06-03
(Press-News.org) Berlin, Germany:  Aneuploidy (the presence of an abnormal number of chromosomes) in embryos is a major cause of impaired embryo development, leading to conditions such as Down syndrome, as well as to pregnancy loss. The transfer of such embryos in women undergoing IVF is therefore usually avoided because of unfavourable pregnancy outcomes. But mosaic embryos, comprising both genetically normal and abnormal cells, can result in perfectly normal babies. Now, researchers have been able to understand how these mosaic embryos self-correct to develop normally. This understanding will improve the numbers of embryos suitable for transfer in women undergoing IVF, they say.

Presenting their results to the annual conference of the European Society of Human Genetics today (Monday), Ms Sheila Kwok, a PhD candidate in the Physiology Department of the University of Toronto, Toronto, Canada, will explain how the existence of a self-correction mechanism in mosaic embryos is consistent with the results of a large-scale clinical study of over 3500 pregnancy outcomes from mosaic embryo transfers from the International Registry of Mosaic Embryo Transfers (IRMET)* - where only 1.2% of preimplantation mosaicism persisted throughout pregnancy or postnatally. These findings, in turn, will reduce the stress on patients who have only mosaic embryos available for transfer, they say.

There has been an increasing number of women postponing motherhood over the past two decades. As they age, they become more likely to produce genetically abnormal embryos, due to higher error rates during egg development. This poses a challenge for women wishing to balance reproductive health with motherhood, since in IVF genetically normal embryos are prioritised for transfer to shorten time to pregnancy and reduce miscarriage and abnormal pregnancies. In older women, this can be very limiting, and therefore mosaic embryos are often the only available choice. Understanding how and which mosaic embryos will develop normally is therefore of ultimate importance.

“From earlier work carried out at the CReATe Fertility Centre, Toronto by Drs Clifford Librach and Mitko Madjunkov, we knew that mosaic embryos could result in ongoing pregnancies and live births at a rate of around 30%, which is lower than those from embryos with normal number of chromosomes (euploid embryos). This enabled us to start using mosaic embryos for transfer where no euploid embryos were available, but we still did not fully understand the process by which they self-corrected,” says Ms Kwok.

All pregnancies, natural or assisted, have around 3% risk of having an abnormal child. The 1.2% persistence of mosaicism therefore does not exceed this risk but prompts researchers to continue searching for answers. “We will expand our research to look at embryos with specific chromosomal aberrations to understand if this clearance mechanism is specific to the chromosome being affected,” says Ms Kwok. And, for all women who have a mosaic embryo transfer, current recommendations are prenatal testing and close pregnancy monitoring.”

 

 

By utilising advanced single-cell transcriptomic analysis1 and post-implantation embryo culturing systems, the researchers have now been able to address how two cell populations with differential fitness levels are able to co-exist in the same environment, and what are the mechanisms inducing the depletion of the abnormal cells. Their findings pointed to the fact that abnormal cells were less able to survive than normal cells, which had higher fitness. They now plan to use gene editing technology with stem cell-derived embryo models to validate the importance of the genes and molecular functions they have identified in these processes. In the future, they will apply small molecule treatments2 on mosaic embryos to try to facilitate this self-correction process.

“Embryology and assisted reproductive technologies have come a long way from the initial success rates of around 10-20%. In the last 10 years with advanced genetic tests for embryo selection rates have been close to 50-60%”, says Dr Svetlana Madjunkova MD, PhD, Head of Reproductive Genetics at CReATe Fertility Centre, the senior author of this work and the founder of IRMET. “But we still need to improve our understanding of which embryos to prioritise for transfer, to optimise patient treatment, help patients achieve their family goals and prevent the waste of time and resources, not to mention patient emotional and psychological stress, involved in transferring embryos that are not viable, and the complications associated with multiple embryo transfer. Our results, elucidating some of the mechanisms controlling normal embryo development, are providing strong evidence to believe that we have made an important step down this path.”

Professor Alexandre Reymond, from the Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland, and chair of the conference, said: “Juggling career and parenthood is difficult and often induces couples to become parents are an older age. While this increases genetic risk, we are now beginning to understand how to mitigate it.”

(ends) 

*www.irmet.net

1. Single-cell transcriptomics examines the gene expression level of individual cells in a given population.

2.Small molecules are chemical compound that target specific biological processes or pathways in cells without introducing genetic modifications.

Abstract no. 5084 Single-cell transcriptomics of post-implantation embryos: unveiling aneuploidy effects and lineage dynamics.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

Metformin may be as safe as insulin during pregnancy, 11-year data shows

2024-06-02
BOSTON—Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. This is the first study to look at longer term effects of metformin use during pregnancy. “Metformin has been extensively used for managing raised blood glucose values in pregnancy for many decades now. It is the only blood glucose-lowering oral medication approved ...

Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes

2024-06-02
BOSTON—GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “Before this study, there was limited information about how these specific diabetes medications work in patients with both type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD),” said Alexander Kutz, M.D., M.P.H., M.Sc., a research fellow in the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, at Brigham ...

Neoadjuvant Immunotherapy for early stage melanoma shows positive results

Neoadjuvant Immunotherapy for early stage melanoma shows positive results
2024-06-02
Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Fifty-nine percent of patients responds so well to this therapy that adjuvant treatment is no longer needed, according to the results of the NADINA study that were published today. The NADINA study, led by researchers from the Netherlands Cancer Institute, was named one of the eleven clinical studies with the biggest impact on health care in 2024 by Nature Medicine. The study now proves that this was not an empty claim, as shown by the results presented by medical oncologist and research leader Christian Blank today during ASCO 2024, the international congress ...

CDC reports its decade-long efforts in standardizing vitamin D tests

2024-06-02
BOSTON—Vitamin D tests certified by the U.S. Centers for Disease Control and Prevention (CDC) Clinical Standardization Programs (CSP) are well calibrated overall, according to a new study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. However, the researchers found some inaccuracies among the assays studied. The blood tests show an “appropriate” level of analytical accuracy, said the study’s lead researcher, Otoe Sugahara, manager of the CDC Vitamin D Standardization-Certification Program (VDSCP) in Atlanta, Ga. Analytical accuracy is the test’s ability to correctly analyze vitamin D in this ...

Persons of nonbinary gender may desire lower-dose testosterone treatment than guidelines recommend

2024-06-02
BOSTON—Among transgender and gender-diverse adults whose gender identity is nonbinary—not exclusively male or female—and who choose low-dose hormone treatment, most prefer to continue testosterone therapy at lower-than-recommended doses after at least six months of treatment, a new study finds. The study will be presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “Current guidelines for initiation of testosterone for gender affirmation assume that transgender and gender-diverse, or trans, individuals desire both rapid and complete masculinization,” ...

High insulin levels contribute to worse outcomes for Black women with aggressive form of breast cancer

2024-06-02
BOSTON—High insulin levels contribute to worse outcomes for Black women compared to white women who have an aggressive form of breast cancer called triple-negative breast cancer, according to a study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. Triple-negative breast cancer accounts for about 10-15% of all breast cancers. The term triple-negative breast cancer refers to the fact that the cancer cells do not have estrogen or progesterone receptors and do not make any or too much of the protein called HER2. The cells test ‘negative’ on all 3 tests. Triple-negative breast ...

Stress from living in violent neighborhoods tied to aggressive lung cancer in Black men

2024-06-02
BOSTON—Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, cortisol, which may influence the aggressiveness of lung cancer, according to data presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “This research uncovers a previously unknown link between exposure to neighborhood violence, GR and lung tumor aggressiveness that can help us understand and fix the lung cancer health disparity seen in Black men” said Hannah Heath, B.S., a graduate research assistant ...

Thyroid eye disease patients report maintained improvement 2 years after teprotumumab infusions

2024-06-02
BOSTON—Most patients with thyroid eye disease treated with teprotumumab didn’t require additional treatments nearly 2 years later, according to industry-supported research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass., and published in the journal Thyroid. “Thyroid eye disease is a lifelong autoimmune disease that can worsen or flare, regardless of how it has been treated. This is the case for many autoimmune diseases,” said George Kahaly, M.D., Ph.D., professor of medicine and endocrinology at Johannes Gutenberg University Medical Center in Mainz, Germany. “Given the enduring nature ...

More women report hip fractures earlier in life

2024-06-02
BOSTON—Older women with low bone density are more likely to experience their first hip fracture in their 60s compared to older ages, according to research being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. “Older women experience an increased risk of fragility hip fractures. These are hip fractures with minimal trauma or due to a fall from a standing height, and they are often deadly and disabling,” said Avica Atri, M.D., an Internal Medicine resident physician at Jefferson Einstein Hospital in Philadelphia, Pa. “As the population over 60 swells in the United States, a large proportion of women will be ...

Cutting-edge robotics: Introducing the hybrid-driven origami gripper

Cutting-edge robotics: Introducing the hybrid-driven origami gripper
2024-06-02
In an impressive leap forward for robotics technology, researchers from Shanghai Jiao Tong University have unveiled a novel hybrid-driven origami gripper, designed to tackle the challenge of grasping and manipulating objects with unprecedented versatility and precision. This innovative device, highlighted in a recent study published in Cyborg Bionic Systems, promises to reshape the capabilities of robotic systems in industries ranging from manufacturing to healthcare. The newly developed gripper utilizes a combination of pneumatic and cable-driven mechanisms to control an origami-inspired structure, allowing for adjustable finger stiffness and variable finger lengths. This sophisticated ...

LAST 30 PRESS RELEASES:

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

A step toward plant-based gelatin

ECMWF unveils groundbreaking ML tool for enhanced fire prediction

The food and fuel that farms itself

Patient- and Community-Level Characteristics Associated With RSV Vaccination

[Press-News.org] Understanding how abnormal embryos self-correct may provide women with a better chance of IVF pregnancy